Table of Contents

HK J Paediatr (New Series)
Vol 11. No. 2, 2006

HK J Paediatr (New Series) 2006;11:128-132

Original Article

Adolescent Primary Spontaneous Pneumothorax: A Hospital's Experience

YW Hui, KW Chan, CK Chung, S Ko, LS Lam, KL Wu, SC Young


Abstract

Objective: To study the demographic and clinical characteristics of adolescent primary spontaneous pneumothorax (PSP). Methods: Adolescent patients (age 10-18 years) with first presentation of PSP were recruited in this retrospective cohort study. Four categories of data, including demography, clinical symptoms at presentation, disease progress and recurrence were retrieved from the hospital records. Results: Ninety episodes of PSP in 63 patients (55 males and 8 females) were identified. The mean (SD) height, weight and body mass index percentiles were 60.2% (27.9%), 35.0% (21.1%) and 29.9% (21.8%) respectively. The commonest symptoms at presentation were chest pain or discomfort (90.5%) and shortness of breath (42.9%); none of them had cardiopulmonary compromise. Nineteen patients were treated conservatively whereas 29 and 15 patients were treated by tube thoracostomy and surgery respectively. There were totally 22 (34.9%) patients who suffered from recurrence, and the recurrence rates for the conservative, tube thoracostomy and surgery treatment groups were 26.3% (5/19), 52.7% (15/29) and 13.3% (2/15) respectively. Fifteen (68%) of the 22 recurrences occurred within 3 months after the first presentation. Conclusion: Adolescent PSP occurs mainly in tall thin boys of late teenage group and all of them are clinically stable. Conservative treatment can be considered for small PSP of size less than 30%. Tube thoracostomy should be considered in large PSP or failed conservative treatment. For patients treated with tube thoracostomy, persistent leakage (longer than 7 days) warrants surgical treatment.

Keyword : Adolescent; Primary spontaneous pneumothorax; Recurrence


Abstract in Chinese

 
 

©2018 Hong Kong Journal of Paediatrics. All rights reserved. Developed and maintained by Medcom Ltd.